Immunomodulatory effects of the ether phospholipid edelfosine in experimental autoimmune encephalomyelitis

Standard

Immunomodulatory effects of the ether phospholipid edelfosine in experimental autoimmune encephalomyelitis. / Abramowski, Pierre; Steinbach, Karin; Zander, Axel R; Martin, Roland.

In: J NEUROIMMUNOL, Vol. 274, No. 1-2, 15.09.2014, p. 111-24.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

APA

Vancouver

Bibtex

@article{e031a269806a439586f35139441f1ffe,
title = "Immunomodulatory effects of the ether phospholipid edelfosine in experimental autoimmune encephalomyelitis",
abstract = "The 2-lysophosphatidylcholine analog edelfosine induces apoptosis in highly proliferating cells, e.g. activated immune cells. We examined mechanisms of action of edelfosine on immune functions in experimental autoimmune encephalomyelitis, a well-accepted animal model for multiple sclerosis. We observed activated caspase-3 expression in lymphoid organs and the central nervous system; however, edelfosine did not induce global apoptosis. Edelfosine improved the disease course and led to reduced frequencies of CD4(+) T cells infiltrating into the central nervous system. Our data suggest edelfosine as an interesting treatment candidate for multiple sclerosis.",
keywords = "Animals, Apoptosis, Cell Proliferation, Cells, Cultured, Disease Models, Animal, Encephalomyelitis, Autoimmune, Experimental, Female, Immunologic Factors, Male, Mice, Mice, Inbred C57BL, Multiple Sclerosis, Phosphodiesterase Inhibitors, Phospholipid Ethers, T-Lymphocytes",
author = "Pierre Abramowski and Karin Steinbach and Zander, {Axel R} and Roland Martin",
note = "Copyright {\textcopyright} 2014 Elsevier B.V. All rights reserved.",
year = "2014",
month = sep,
day = "15",
doi = "10.1016/j.jneuroim.2014.07.007",
language = "English",
volume = "274",
pages = "111--24",
journal = "J NEUROIMMUNOL",
issn = "0165-5728",
publisher = "Elsevier",
number = "1-2",

}

RIS

TY - JOUR

T1 - Immunomodulatory effects of the ether phospholipid edelfosine in experimental autoimmune encephalomyelitis

AU - Abramowski, Pierre

AU - Steinbach, Karin

AU - Zander, Axel R

AU - Martin, Roland

N1 - Copyright © 2014 Elsevier B.V. All rights reserved.

PY - 2014/9/15

Y1 - 2014/9/15

N2 - The 2-lysophosphatidylcholine analog edelfosine induces apoptosis in highly proliferating cells, e.g. activated immune cells. We examined mechanisms of action of edelfosine on immune functions in experimental autoimmune encephalomyelitis, a well-accepted animal model for multiple sclerosis. We observed activated caspase-3 expression in lymphoid organs and the central nervous system; however, edelfosine did not induce global apoptosis. Edelfosine improved the disease course and led to reduced frequencies of CD4(+) T cells infiltrating into the central nervous system. Our data suggest edelfosine as an interesting treatment candidate for multiple sclerosis.

AB - The 2-lysophosphatidylcholine analog edelfosine induces apoptosis in highly proliferating cells, e.g. activated immune cells. We examined mechanisms of action of edelfosine on immune functions in experimental autoimmune encephalomyelitis, a well-accepted animal model for multiple sclerosis. We observed activated caspase-3 expression in lymphoid organs and the central nervous system; however, edelfosine did not induce global apoptosis. Edelfosine improved the disease course and led to reduced frequencies of CD4(+) T cells infiltrating into the central nervous system. Our data suggest edelfosine as an interesting treatment candidate for multiple sclerosis.

KW - Animals

KW - Apoptosis

KW - Cell Proliferation

KW - Cells, Cultured

KW - Disease Models, Animal

KW - Encephalomyelitis, Autoimmune, Experimental

KW - Female

KW - Immunologic Factors

KW - Male

KW - Mice

KW - Mice, Inbred C57BL

KW - Multiple Sclerosis

KW - Phosphodiesterase Inhibitors

KW - Phospholipid Ethers

KW - T-Lymphocytes

U2 - 10.1016/j.jneuroim.2014.07.007

DO - 10.1016/j.jneuroim.2014.07.007

M3 - SCORING: Journal article

C2 - 25086877

VL - 274

SP - 111

EP - 124

JO - J NEUROIMMUNOL

JF - J NEUROIMMUNOL

SN - 0165-5728

IS - 1-2

ER -